Results

Total Results: 444 records

Showing results for "malignant neoplasm".

341. Neds 2012 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2012_MaskedStats_Core.PDF
     January 01, 2012 - cancer of skin 721 0.00 24: Cancer of breast 2,828 0.01 25: Cancer of uterus 1,071 0.00 26: Cancer … primary 811 0.00 42: Secondary malignancies 27,692 0.09 43: Malignant neoplasm without specification … of site 1,671 0.01 44: Neoplasms of unspecified nature or uncertain behavior 7,627 0.02 45: Maintenance … chemotherapy; radiotherapy 1,049 0.00 46: Benign neoplasm of uterus 11,461 0.04 47: Other and unspecified … benign neoplasm 12,683 0.04 48: Thyroid disorders 11,213 0.04 49: Diabetes mellitus without complication

342. Neds 2013 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2013_MaskedStats_Core.PDF
     January 01, 2013 - cancer of skin 648 0.00 24: Cancer of breast 2,741 0.01 25: Cancer of uterus 1,028 0.00 26: Cancer … ; other and unspecified primary 799 0.00 42: Secondary malignancies 26,369 0.09 43: Malignant neoplasm … without specification of site 1,669 0.01 44: Neoplasms of unspecified nature or uncertain behavior … 7,194 0.02 45: Maintenance chemotherapy; radiotherapy 1,043 0.00 46: Benign neoplasm of uterus 10,930 … 0.04 47: Other and unspecified benign neoplasm 12,521 0.04 48: Thyroid disorders 10,528 0.04 49:

343. Neds 2009 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2009_MaskedStats_Core.PDF
     January 01, 2009 - cancer of skin 552 0.00 24: Cancer of breast 2,454 0.01 25: Cancer of uterus 924 0.00 26: Cancer … ; other and unspecified primary 747 0.00 42: Secondary malignancies 27,840 0.10 43: Malignant neoplasm … without specification of site 1,464 0.01 44: Neoplasms of unspecified nature or uncertain behavior … 7,337 0.03 45: Maintenance chemotherapy; radiotherapy 952 0.00 46: Benign neoplasm of uterus 9,031 … 0.03 47: Other and unspecified benign neoplasm 11,942 0.04 48: Thyroid disorders 8,804 0.03 49: Diabetes

344. Neds 2011V2 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2011v2_MaskedStats_Core.PDF
     November 03, 2014 - cancer of skin 526 0.00 24: Cancer of breast 2,431 0.01 25: Cancer of uterus 963 0.00 26: Cancer … primary 823 0.00 42: Secondary malignancies 26,094 0.09 43: Malignant neoplasm without specification … of site 1,478 0.01 44: Neoplasms of unspecified nature or uncertain behavior 7,271 0.03 45: Maintenance … chemotherapy; radiotherapy 688 0.00 46: Benign neoplasm of uterus 10,327 0.04 47: Other and unspecified … benign neoplasm 11,856 0.04 48: Thyroid disorders 10,024 0.03 49: Diabetes mellitus without complication

345. Neds 2011 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2011_MaskedStats_Core.PDF
     January 01, 2011 - cancer of skin 547 0.00 24: Cancer of breast 2,517 0.01 25: Cancer of uterus 989 0.00 26: Cancer … primary 841 0.00 42: Secondary malignancies 27,423 0.09 43: Malignant neoplasm without specification … of site 1,529 0.01 44: Neoplasms of unspecified nature or uncertain behavior 7,468 0.03 45: Maintenance … chemotherapy; radiotherapy 704 0.00 46: Benign neoplasm of uterus 10,434 0.04 47: Other and unspecified … benign neoplasm 12,237 0.04 48: Thyroid disorders 10,272 0.03 49: Diabetes mellitus without complication

346. Neds 2010 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2010_MaskedStats_Core.PDF
     January 01, 2010 - cancer of skin 545 0.00 24: Cancer of breast 2,380 0.01 25: Cancer of uterus 866 0.00 26: Cancer … primary 812 0.00 42: Secondary malignancies 26,383 0.09 43: Malignant neoplasm without specification … of site 1,433 0.01 44: Neoplasms of unspecified nature or uncertain behavior 7,093 0.02 45: Maintenance … chemotherapy; radiotherapy 910 0.00 46: Benign neoplasm of uterus 9,865 0.03 47: Other and unspecified … benign neoplasm 11,948 0.04 48: Thyroid disorders 9,261 0.03 49: Diabetes mellitus without complication

347. Autopsy Revelation | PSNet
     psnet.ahrq.gov/web-mm/autopsy-revelation
     December 01, 2007 - For instance, one of the studies in the autopsy literature specifically looked at cancer misdiagnoses … Autopsy diagnoses of malignant neoplasms: how often are clinical diagnoses incorrect?

348. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - , accounting for about 1 percent of all cancer types,1 and the second most common hematologic malignancy … Notwithstanding, SFLC testing has the highest sensitivity for detecting light chain production by tumors … SEER cancer statistics review, 1975-2003. NCI, Bethesda, MD; 2005. … Cancer Statistics, 2007. … search, we ran an alternative search strategy crossing four new terms (Multiple myeloma* OR Plasma cell neoplasms

349. Neds 2014 Maskedstats Core (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2014_MaskedStats_Core.PDF
     January 01, 2014 - non-epithelial cancer of skin 714 0.00 24: Cancer of breast 3,093 0.01 25: Cancer of uterus 1,198 0.00 … ; other and unspecified primary 828 0.00 42: Secondary malignancies 27,580 0.09 43: Malignant neoplasm … without specification of site 1,751 0.01 44: Neoplasms of unspecified nature or uncertain behavior … 7,683 0.02 45: Maintenance chemotherapy; radiotherapy 1,049 0.00 46: Benign neoplasm of uterus 13,295 … 0.04 47: Other and unspecified benign neoplasm 13,659 0.04 48: Thyroid disorders 11,693 0.04 49:

350. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
     January 10, 2012 - cell-directed therapy suggest an immunologic nature of the disease. 8,9 Various cytokines, like tumor … We have not listed specific malignancies (hepatosplenic T-cell lymphoma and other lymphomas) and infections … of first- line therapy including full-dose nonsteroidal anti-inflammatory agents; trophoblastic neoplasms … for this indication Cyclophos- phamide‡ Cytoxan ® (injectable) Baxter Healthcare Treatment of malignancies … parameters (e.g. glucose, lipids, weight, BMI, thyroid function)  Injection site reaction  Malignancy

351. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - II Colon Cancer Colon cancer is a common malignancy affecting both women and men. … peritoneum), and IIC (T4b tumors where tumor directly invades or is adherent to other organs or structures … Colon cancer is a common malignancy in both women and men. … Search Strategy for MEDLINE® 1. exp Colorectal Neoplasms/ 2. … ((colorectal or colon$ or rectal or Sigmoid) adj3 (neoplasm$ or cancer$ or carcino$ or tumo?

352. Healthcare Cost and Utilization Project (HCUP) NIS Notes
     hcup-us.ahrq.gov/db/vars/dxn/nisnote.jsp
     September 01, 2008 - Fever 6200 29 Follicular Cyst of Ovary 2400 24 Simple Goiter 1600 11 Malignant … Neoplasm of Nasal Cavities 2100 8 Benign Neoplasm of Lip 3201 3 Pneumococcal Meningitis

353. Overuse of Computed Tomography Scans for the Evaluation of Children with a First Generalized Afebrile, Atraumatic Seizure: Report (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-fullreport.pdf
     November 01, 2019 - , and other malignancies later in life (Mathews, et al., 2013; Pearce, et al., 2012). … delayed milestone. 5 o Pre-existing conditions that would warrant imaging, such as neoplasm … anomalies, hemangioma, phlebitis/thrombophlebitis, occlusion of cerebral arteries, moyamoya disease, tumor … radiosensitive than those of adults; children, therefore, will be at substantially elevated risk for malignancy … , and other malignancies later in life.

354. Children with Disabilities Algorithm (CWDA) A Claims-Based Tool for Identifying Children with Disabilities (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-section-2.pdf
     January 01, 2020 - NEOPLASMS (140 239) Malignant Neoplasm Of Other And Unspecified Sites (190-199) 1910 Malign neopl … optic atrophy 37713 Optic atrph w retin dyst 37714 Cupping of optic disc 37771 Vis cortx dis w neoplasm

355. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
     May 18, 2021 - Main Outcomes and Measures: Colorectal cancer incidence and mortality, test accuracy in detecting cancers … Among all cancers, it is third in incidence and cause of cancer death for both men and women. 1 In addition … entails exposure to low-dose ionizing radiation (range, 0.8 to 5.3 mSv), which may increase the risk of malignancy … Interval cancers in a population-based screening program for colorectal cancer in Catalonia, Spain. … Extracolonic tumors of the gastrointestinal tract detected incidentally at screening CT colonography.

356. Cell-Free-Dna-Appendix-C-Prepub-Final (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
     January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35 Solid tumors: 19/35 (53%) Hematologic: 17/35 (47%) TP with new cancer:

357. Cell-Free-Dna-Final-App-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
     January 01, 2025 - Neoplasia. 2023 Dec;46:100941. doi: 10.1016/j.neo.2023.100941. PMID: 37918207. … Validation cohort ("V") included 82 participants with GI cancers, 11 participants with benign tumors, … The diagnostic performance of the tumor markers for GI cancer screening (analysis 1) and whole-body cancer … Staging per TNM Classification of Malignant Tumors by Union for International Cancer Control, 8th ed. … Both new and recurrent: 1/35 Solid tumors: 19/35 (53%) Hematologic: 17/35 (47%) TP with new cancer:

358. User Guide (v2025.1) for Elixhauser Comorbidity Software Refined for ICD-10-CM (pdf file)
     hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2025-1.pdf
     November 01, 2024 - • Removed C80.1, Malignant (primary) neoplasm, unspecified, and R180, Malignant ascites, as these … are not indicative of metastatic cancer. … • Focused this measure on solid malignant tumors without metastasis, starting with v2021.1. … • Added diagnosis codes that align with the National Cancer Institute’s classification of cancer … Additionally, added diagnosis codes indicative of cancers of the skin.

359. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
     November 01, 2007 - Based on outpatient or inpatient claim for cancer or cancer-related care using the following ICD- … 9 codes: ICD-9-CM Codes Diagnosis (in preferred ICD-O-3 terminology) 140.0 - 208.9 Malignant neoplasms … 9733/3) 205.1 Chronic neutrophilic leukemia (9963/3) 230.0 - 234.9 Carcinoma in situ 235.0 - 238.9 Neoplasms … Cost of care for patients in cancer clinical trials. … J Natl Cancer Inst 2000;92(2):136-42.

360. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
     May 18, 2021 - incidence (excluding tumors that are not the target of colorectal cancer screening) among 20- to 44- … that are not the target of colorectal cancer screening (eg, carcinoid tumors). … or in addition) by faster progression to malignancy is unknown. … Contributions of adenocarcinoma and carcinoid tumors to early-onset colorectal cancer incidence rates … Prevalence of advanced, precancerous colorectal neoplasms in black and white populations: a systematic